317 related articles for article (PubMed ID: 11527109)
21. [Beta-adrenergic receptor blockers in clinical practice].
Czuriga I; Edes I
Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 1,2-benzisothiazolyloxypropanolamine derivatives and investigation of their activity at beta-adrenoceptors.
Morini G; Pozzoli C; Menozzi A; Comini M; Poli E
Farmaco; 2005 Oct; 60(10):810-7. PubMed ID: 16154571
[TBL] [Abstract][Full Text] [Related]
23. The role of catecholamines in ischemia.
Schömig A; Richardt G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S105-12. PubMed ID: 11527112
[TBL] [Abstract][Full Text] [Related]
24. Temporal dynamics of inotropic, chronotropic, and metabolic responses during beta1- and beta2-AR stimulation in the isolated, perfused rat heart.
McConville P; Spencer RG; Lakatta EG
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E412-8. PubMed ID: 15840637
[TBL] [Abstract][Full Text] [Related]
25. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
Höcht C; Opezzo JA; Gironacci MM; Peña C; Taira CA
Clin Exp Pharmacol Physiol; 2005; 32(1-2):30-4. PubMed ID: 15730431
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological evaluation of ocular beta-adrenoceptors in rabbit by tissue segment binding method.
Horinouchi T; Morishima S; Tanaka Y; Koike K; Miwa S; Muramatsu I
Life Sci; 2009 Jan; 84(5-6):181-7. PubMed ID: 19087880
[TBL] [Abstract][Full Text] [Related]
27. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.
Barki-Harrington L; Luttrell LM; Rockman HA
Circulation; 2003 Sep; 108(13):1611-8. PubMed ID: 12963634
[TBL] [Abstract][Full Text] [Related]
28. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
[TBL] [Abstract][Full Text] [Related]
29. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
Kaye DM; Smirk B; Finch S; Williams C; Esler MD
J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
[TBL] [Abstract][Full Text] [Related]
30. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
Prichard BN; Saul PA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
[TBL] [Abstract][Full Text] [Related]
31. Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarction.
Willerson JT; Buja LM
Postgrad Med; 1988 Feb; Spec No():27-32. PubMed ID: 2894660
[TBL] [Abstract][Full Text] [Related]
32. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Chen J; Zhang LF; Han C; Yu GS; Ma J
J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
[TBL] [Abstract][Full Text] [Related]
33. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
34. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
Wellstein A; Palm D; Belz GG; Pitschner HF
Arzneimittelforschung; 1985; 35(1):2-6. PubMed ID: 2859024
[TBL] [Abstract][Full Text] [Related]
35. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
36. Fundamental considerations of beta-adrenoceptor subtypes in human heart failure.
Molenaar P; Parsonage WA
Trends Pharmacol Sci; 2005 Jul; 26(7):368-75. PubMed ID: 15936831
[TBL] [Abstract][Full Text] [Related]
37. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
38. Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia.
Arnold AS; Tang YL; Qian K; Shen L; Valencia V; Phillips MI; Zhang YC
J Hypertens; 2007 Jan; 25(1):197-205. PubMed ID: 17143192
[TBL] [Abstract][Full Text] [Related]
39. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
Dotzer F; Gromer H
Fortschr Med; 1993 Aug; 111(24):382-4. PubMed ID: 8104853
[TBL] [Abstract][Full Text] [Related]
40. [Role of myocardial beta-adrenergic receptors in cardiac insufficiency].
Gibelin P; Sbirrazzuoli V; Drici M; Bossan P; Baudouy M; Lapalus P; Morand P
Ann Cardiol Angeiol (Paris); 1990 Mar; 39(3):165-71. PubMed ID: 2160789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
